BCL6-IN-5
BCL6-IN-5 is a potent BCL6 inhibitor exacted from patent WO2018215801A1, example 1n, has a pIC50 of 5.82[1].
Product Specifications
CAS Number
2253878-09-8
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Bcl-2 Family
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bcl6-in-5.html
Concentration
10mM
Purity
99.82
Solubility
DMSO : 20.83 mg/mL (ultrasonic)
Smiles
O=C1N(CCC(C)(O)C)C2=CC(NC3=NC(Cl)=NC=C3Cl)=CC=C2N1C
Molecular Formula
C17H19Cl2N5O2
Molecular Weight
396.27
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362-P403+P233-P405-P501
References & Citations
[1]Benjamin Richard BELLENIE, et al. Benzimidazolone derived inhibitors of bcl6. WO2018215801A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC473276-500 1x 500 µL
Cathepsin D (Tumor Marker) (CTSD/3276), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
